IP Library Granted Patent US 11,414,393
Granted Patent B2
US 11,414,393 · App. 17/070,486 · Granted Aug 16, 2022

Aminoalcohol lipidoids and uses thereof

Inventors: Kerry Peter Mahon (Cambridge, MA); Kevin Thomas Love (Boston, MA); Christopher G. Levins (Flemington, NJ); Kathryn Ann Whitehead (Pittsburgh, PA); Robert S. Langer (Newton, MA); Daniel Griffith Anderson (Framingham, MA)
Assignee: Massachusetts Institute of Technology
C07D295/13A61K9/107A61K9/1271A61K9/5123A61K31/7088A61K38/02A61K47/16A61K47/54A61K47/545A61K48/0025C07C215/14C07C217/08C12N15/111C12N15/1137C12N15/88B01J2531/0252B01J2531/845C12N2310/14C12N2310/3515C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,414,393
App. No.
17/070,486
Granted
Aug 16, 2022
Kind
B2
Abstract

Aminoalcohol lipidoids are prepared by reacting an amine with an epoxide-terminated compound are described. Methods of preparing aminoalcohol lipidoids from commercially available starting materials are also provided. Aminoalcohol lipidoids may be prepared from racemic or stereochemically pure epoxides. Aminoalcohol lipidoids or salts forms thereof are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems. Given the amino moiety of these aminoalcohol lipidoid compounds, they are particularly suited for the delivery of polynucleotides. Complexes, micelles, liposomes or particles containing the inventive lipidoids and polynucleotide have been prepared. The inventive lipidoids may also be used in preparing microparticles for drug delivery. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.

Claims (41)

1. A method of preparing an aminoalcohol lipidoid compound of the formula:

or a pharmaceutically acceptable salt, wherein:

R A and R F independently are hydrogen,

R Y and R Z independently are hydrogen,

each R 5 is independently selected from:

m is 1; and

p is 1;

the method comprising the step of reacting one or more equivalents of an amine of the formula:

with one or more epoxide-containing compounds selected from:

2. The method of claim 1 , wherein R A is:

3. The method of claim 1 , wherein R F is:

4. The method of claim 1 , wherein:

RA is:

and

R F is:

5. The method of claim 1 , wherein:

RA is:

and

R F is:

6. The method of claim 1 , wherein R Y and R Z independently are hydrogen, or

7. The method of claim 6 , wherein R Y and R Z are

8. The method of claim 1 , wherein R A is:

9. The method of claim 1 , wherein R F is:

10. The method of claim 1 , wherein the aminoalcohol lipidoid compound is selected from:

and

pharmaceutically acceptable salts thereof.

11. The method of claim 10 , wherein the aminoalcohol lipidoid compound is:

or a pharmaceutically acceptable salt thereof.

12. The method of claim 1 , wherein the method comprises reacting one or more equivalents of an amine of the formula:

with an epoxide-containing compound of the formula:

13. The method of claim 12 , wherein the aminoalcohol lipidoid compound is:

or a pharmaceutically acceptable salt thereof.

14. The method of claim 12 , wherein the epoxide-containing compound is:

and the aminoalcohol lipidoid compound is:

or a pharmaceutically acceptable salt thereof.

15. The method of claim 1 , wherein the step of reacting is performed with no solvent present.

16. The method of claim 1 , wherein the step of reacting is performed in the presence of an aprotic solvent.

17. The method of claim 1 , wherein the step of reacting is performed in the presence of a solvent selected from tetrahydrofuran, diethyl ether, ethyl acetate, DMSO, DMF, methanol, ethanol, and water.

18. The method of claim 1 , wherein the step of reacting is performed at a temperature ranging from 25° C. to 100° C.

19. The method of claim 18 , wherein the step of reacting is performed at approximately 90° C.

20. The method of claim 1 , further comprising the step of purifying the aminoalcohol lipidoid compound.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 12, 2022
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061656/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2021
From: MAHON, KERRY PETER; LOVE, KEVIN THOMAS; LEVINS, CHRISTOPHER G.; WHITEHEAD, KATHRYN ANN; LANGER, ROBERT S.; ANDERSON, DANIEL GRIFFITH
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 057778/0874 →
Continuity (7)
Division 16208295 · Dec 3, 2018
Continuation 15417530 · Jan 27, 2017
Continuation 14599004 · Jan 16, 2015
Division 13128020
Provisional Application 61166518 · Apr 3, 2009
Provisional Application 61112414 · Nov 7, 2008
Related Publication 20210101875A1 · Apr 8, 2021
Cited By (3)
US 12,390,528 US 12,648,959 US 12,685,787